Katharina Brett

Katharina Brett is a seasoned professional in the life sciences and healthcare sectors with extensive experience in medical advisory roles and clinical research. Currently serving as a Senior Medical Advisor and Study Accountable Person at ViiV Healthcare since June 2024, Katharina has previously held significant positions at Jazz Pharmaceuticals as a National Medical Advisor in Haematology/Oncology, and at AstraZeneca as a Medical Science Liaison in Oncology. A background in clinical project management was established during tenure at BIOTRONIK, where responsibilities included overseeing clinical studies and ensuring compliance with regulatory standards. Alongside this professional experience, Katharina has academic credentials as a PhD candidate at Freie Universität Berlin, contributing to scientific research and publications. Leadership roles include Chairwoman for the Young European Biotech Network, actively promoting collaboration within the European biotech community. Educational qualifications comprise a Diplom in Biology, Biochemistry, and Molecular Biology from Humboldt-Universität zu Berlin, and a Doctorate in Virology from the same institution.